Skip to content Without the hassle of having to manage people and processes.
BPO in RA is an annual subscription service for the complete management of Regulatory Affairs with ANVISA.
We offer everything that a regulatory department can provide, without the hassle of having to manage people and processes in a market with a different culture than the contracting company.
If your company has more than 4 products registered or to be registered in Brazil with ANVISA, we are your best solution!
For fewer registrations, contact us.
With almost 30 years' experience in the Brazilian market.
Specialized in your product.
Proin eget tortor risus. Vivamus magna justo. (texto marcação)
To issue import authorizations and other services such as post-market control.
You may have already heard this statement and even believe it.
And it’s true that accessing this market can be complex and costly. However, with BPO in RA, we are able to devise the best strategy for overcoming any difficulties.
Concerned about the issues below?
With almost three decades of knowledge in the regulatory, governmental and commercial areas, Brisa Advisors has broken down these barriers and helped its clients get their product to market.
In the bureaucratic stage of issuing a proposal, contracting, and exchanging unnecessary information.
Hiring a BPO in RA through a subscription service reduces costs and allows you to really know how much will be spent in the year with AR, without surprises.
Definition of the best strategies for the regulatory path in Brazil and in new markets in LATAM.
There is no removal of the employee due to health reasons, maternity leave, or even job rotation.
Avoids labor costs and eventual legal claims.
General Director with 30 years of experience, including working in multinational companies, deep knowledge of the market with legal, regulatory, and commercial vision.
Brisa Advisors, a Regulatory Affairs consulting company, has acted for dozens of small, medium, and large international medical device manufacturing companies before ANVISA, such as Colgate Palmolive, Hoechst, Bayer, Sumitomo, and TELEFLEX group.
Acted in the areas of drugs, food, sanitizing products, cosmetics, and mainly medical devices. It stood out in the first merger case in which they acted to change the understanding of the legislation in force, motivating the change of the regulatory framework of ANVISA.
The change provided significant savings to its client in the payment of fees to ANVISA.
